Empatic®
Empatic® is another
new diet drug in the works that is created by Orexigen Therapeutics. Like Contrave
and Qnexa, Empatic is one drug paired up with another forming a remarkable
mixture for weight loss. Empatic is part Zonisamide and part Bupropion. Zonisamide
is the generic name of the drug, a more common name is the trademark Zonegran®
and Bupropion is often known better as the trademarks Zyban® and Wellbutrin®
the mixtures experimented with range from 120mg of SR (Sustained Release) Zonisamide
to 360mg. The Bupropion SR amounts ranged from 280mg to 360mg. Studies
had people losing upwards of 10% of their body weight during a 24 week period.
This drug definitely meets the FDA requirements for an obesity drug. Side effects
where vary common with other trial medications for weight loss including head
ache, insomnia, nausea among other mild to moderate effects.
As with Tesofensine, Empatic is behind the likes of Contrave, Lorcaserin
and Qnexa in timing. Empatic still needs to undergo stage three testing
to have more proof that it is as effective as it needs to be and shows side effects
within a reasonable rate. Because of the lack of stage three testing results
there is not a lot to report on this medication as of yet. But it definitely
holds much promise if the testing continues to hold the results it has had so
far.
|
